Virax Biolabs is an innovative biotechnology company established in 2013 and based in the United Kingdom. The company's primary focus is on the detection of immune responses to and diagnosis of viral diseases. With a commitment to leveraging biotechnology in the healthcare and life sciences fields, Virax Biolabs has garnered attention from investors, culminating in a Post-IPO Equity investment on 21 August 2024. Although the specific investors for this round are not disclosed, this recent investment signifies a potential growth trajectory for the company in the burgeoning landscape of medical devices and biotechnology.
Virax Biolabs
Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.
Founded 2013
London, United Kingdom
27 employees
Post-IPO Equity
Biotechnology, Health Care +2
London, United Kingdom
27 employees
Post-IPO Equity
Biotechnology, Health Care +2
General Information
Company Name
Virax Biolabs
Founded Year
2013
Location
London, United Kingdom
London, United Kingdom
Founders / Decision Makers
Employees
27
Industries
Biotechnology, Health Care, Life Sciences +1
Funding Stage
Post-IPO Equity
Social
BounceWatch is an independent company data service, not affiliated with Virax Biolabs. To contact Virax Biolabs, visit viraxbiolabs.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Virax Biolabs compare?
A PDF of Virax Biolabs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Virax Biolabs soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Virax Biolabs on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United Kingdom Market
Biotechnology
About Virax Biolabs
Business keywords: Viral diseases, Immune response, In vitro diagnostic, T-Cell testing, COVID-19 diagnosis, Hepatitis B diagnosis, Malaria diagnosis, Human Papilloma Virus diagnosis, Biosensor technology, Point-of-care testing, Medical equipment, Technology, Medical device development
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | Undisclosed | - |
|
21 Aug 2024 |
| Post IPO Equity | Undisclosed | - |
|
08 Mar 2023 |
| Post IPO Equity | Undisclosed | - |
|
04 Nov 2022 |
| Series A | Undisclosed | - |
|
13 Mar 2020 |
| Pre-Seed | Undisclosed | - |
|
24 Sep 2018 |
| Pre-Seed | Undisclosed | - |
|
04 Mar 2016 |
| Pre-Seed | Undisclosed | - |
|
27 Mar 2013 |
Virax Biolabs Alternatives & Competitors
View All Alternatives
Virax Biolabs vs
Cytovale
United States
At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-medi...
Series C
121 employees
AI, Health Care
Virax Biolabs vs
GRIP Molecular Technologies, Inc
United States
Transforming Medical Diagnostics
Non Equity Assistance
12 employees
Biotechnology, Health and Wellness
Virax Biolabs vs
Inflammatix, Inc.
United States
We’re reimagining diagnostics by reading the immune system
Grant
96 employees
Big Data, Biotechnology
KISSH
FAQ About Virax Biolabs
Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.
Virax Biolabs was founded in 2013.
Virax Biolabs is headquartered in London, United Kingdom.
Virax Biolabs operates in Biotechnology, Health Care, Life Sciences and Medical Devices. Its work centres on Viral diseases, Immune response, In vitro diagnostic and T-Cell testing.
Virax Biolabs has approximately 27 employees.
Virax Biolabs has completed 7 funding rounds. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Virax Biolabs include Cytovale, GRIP Molecular Technologies, Inc, Inflammatix, Inc., Avsana Labs, KISSH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Virax Biolabs and Cytovale are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Virax Biolabs, https://bouncewatch.com/company/virax-biolabs, updated 7 January 2025. When citing, please name BounceWatch and link this page.
